| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/09/2006 | EP1688488A1 Bispecific antibody substituting for functional proteins |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688438A2 FXIII subunit b detection for verifying serum sample and sample size and for detecting dilution |
| 08/09/2006 | EP1688437A1 Antibody composition specifically binding to il-5 receptor |
| 08/09/2006 | EP1688436A1 Composition of antibody capable of specifically binding ccr4 |
| 08/09/2006 | EP1688435A1 Methods for determining the activity of Plk1 in human cells |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688433A1 Antibody composition specifically binding to ganglioside gm2 |
| 08/09/2006 | EP1688432A1 Igm high concentration stabilized solution |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688415A1 Cytotoxic agents comprising new C-2 modified taxanes |
| 08/09/2006 | EP1687452A2 Human hinge core mimetibodies, compositions, methods and uses |
| 08/09/2006 | EP1687430A1 Immunization against chlamydia infection |
| 08/09/2006 | EP1687427A2 Methods for modulating neuronal responses |
| 08/09/2006 | EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 08/09/2006 | EP1687420A1 Carboxypertidase u (cpu) mutants |
| 08/09/2006 | EP1687402A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/09/2006 | EP1687338A1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
| 08/09/2006 | EP1687337A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 08/09/2006 | EP1687336A2 Antibodies |
| 08/09/2006 | EP1687335A2 Cancer diagnosis and therapy |
| 08/09/2006 | EP1687331A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family |
| 08/09/2006 | EP1687324A2 Improved expression systems with sec-system secretion |
| 08/09/2006 | EP1687066A2 Methods of modulating immunity |
| 08/09/2006 | EP1687031A1 Pharmaceutical preparation containing an antibody for the egf receptor |
| 08/09/2006 | EP1687029A1 Neutralizing human antibodies to anthrax toxin generated by recall technology |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1687026A1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 08/09/2006 | EP1686970A2 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease |
| 08/09/2006 | EP1686961A1 Solid forms of anti-egfr-antibodies |
| 08/09/2006 | EP1549951A4 Semaphorin-like proteins and methods of using same |
| 08/09/2006 | EP1527190A4 Hip1 cancer markers |
| 08/09/2006 | EP1423429B1 Antibodies against caspase-8, their preparation and use |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1290032B1 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1165750B1 Diagnosis of whipple disease |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | EP1021721B1 Assays for tsh receptor autoantibodies |
| 08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
| 08/09/2006 | EP0939763B1 Directed switch-mediated dna recombination |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | EP0640102B1 Activation-state-specific phosphoprotein immunodetection |
| 08/09/2006 | CN1816567A Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease |
| 08/09/2006 | CN1816565A INF-like secretory protein |
| 08/09/2006 | CN1816352A Methods for treating cancer using an immunotoxin |
| 08/09/2006 | CN1816351A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 08/09/2006 | CN1814623A H5 subtype avian flu virus hemagglutinin protein monoclonal antibody, and its preparing method and use |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1268749C Mateirals and methods for alteration of enzyme and acetyl coA levels in plants |
| 08/09/2006 | CN1268745C Group B streptococcus antigens |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268644C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline E to its high affinity receptor |
| 08/09/2006 | CN1268643C Antibody against SARS-CoV IgY and its preparing method |
| 08/09/2006 | CN1268642C Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/08/2006 | US7087741 Nucleic acids encoding novel proteins in enteroaggregative escherichia coli (EAEC) |
| 08/08/2006 | US7087740 Kits for use in detecting resistance to streptogramin A and related compounds |
| 08/08/2006 | US7087737 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 08/08/2006 | US7087728 Crystal proteins which display stability to harsh environmental conditions; pronase resistance |
| 08/08/2006 | US7087727 Periostin-based diagnostic assays |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087721 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087717 Comprises nucleotide sequences coding nuclear hormone receptor co-activator for diagnosis and treatment of liver disorders |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087409 Grafting; forming libraries; anticancer agents |
| 08/08/2006 | US7087406 Transmembrane protein for use in the diagnosis and treatment of cancer |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087396 Transmembrane proteins produced by hybridomas for distinguishing t-helper cells lines; immunoassays; diagnosing allergies; interleukins |
| 08/08/2006 | US7087393 Methods for detecting CS198 antigen |
| 08/08/2006 | US7087392 Antiproliferative SgK reagents and methods |
| 08/08/2006 | US7087391 Antibody for use in the diagnosis and treatment of inflammation, nephritis, thrombosis, cancer, angina pectoris, liver, blood and brain disorders |
| 08/08/2006 | US7087390 CAIP-like gene family |
| 08/08/2006 | US7087377 Method and kit for detection of tat protein with anti-tat oyi antibodies |
| 08/08/2006 | US7087372 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 08/08/2006 | US7087231 In situ diagnosis of malaria |
| 08/08/2006 | US7087230 Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/08/2006 | US7087228 prevention or prophylaxis of dental caries and endocarditis comprising Streptococcus mutans Competence Stimulating Peptide and sucrose; minimizes the attachment of S. mutans to teeth, and consequently minimize the negative consequences |
| 08/08/2006 | CA2092680C Epstein-barr virus sequences and protein thereof |
| 08/03/2006 | WO2006081553A2 ANTI-MUC1 α/ß ANTIBODIES |
| 08/03/2006 | WO2006081462A2 Multi-component inhibitors of nucleic acid polymerases |
| 08/03/2006 | WO2006081171A1 Humanized anti-amyloid antibody |
| 08/03/2006 | WO2006080867A1 Agent for stimulating the production of a blood coagulation factor viii |
| 08/03/2006 | WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same |
| 08/03/2006 | WO2006080396A1 Quantitative measurement method for recombinant protein |
| 08/03/2006 | WO2006079805A1 Immunoassay for prion disease |
| 08/03/2006 | WO2006079565A2 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 08/03/2006 | WO2006079528A1 Immunoassay for determining the release of neurotensin into the circulation |
| 08/03/2006 | WO2006079372A1 Method for generating variable domain sequences of heavy chain antibodies |
| 08/03/2006 | WO2006057997A3 Plasmin-inhibitory therapies |
| 08/03/2006 | WO2006055871A3 Treatment for multiple sclerosis |
| 08/03/2006 | WO2006037038B1 Optimized vaccines to provide protection against ebola and other viruses |